Assay Kits for Lumipulse instrument
The National Institute on Drug Abuse (NIDA) is seeking to procure assay kits for the Lumipulse G1200 instrument, specifically for quantification of serum/plasma biomarkers abeta42, abeta40, and pTau 217. This acquisition is conducted under Simplified Acquisition Procedures as a Request for Quotation (RFQ) with solicitation number 75N95025Q00005-RFQ. The government will evaluate quotations based on three primary factors: technical capability, price, and past performance, with technical capability and past performance being significantly more important than price. All offerors must have an active registration in the System for Award Management (SAM) and submit their electronic responses by 5:00 p.m. Eastern Time on January 8, 2025, directly to the Contract Specialist Iris Merscher. Quotations must include detailed information such as unit pricing, shipping costs, delivery timeline, product specifications, and other relevant factors that might influence the award decision.
The solicitation is a full and open competition with no specific set-aside restrictions, using the North American Industry Classification System (NAICS) code 325413 for In-Vitro Diagnostic Substance Manufacturing with a small business size standard of 1,250 employees. The total procurement involves 4,410 units of assay kits, divided into two deliveries: Part A of 1,500 units to be shipped after award and Part B of 2,910 units to be shipped within 6 months of award. The government anticipates awarding a firm fixed-price purchase order with delivery f.o.b. destination at 251 Bayview Blvd in Baltimore, Maryland. All items must be manufactured by Fujirebio and specifically designed for use on the Lumipulse G1200 instrument, with the kits intended for use in studying Alzheimer's Disease biomarkers in specimens from the Baltimore Longitudinal Study of Aging (BLSA). The contract will be awarded to the most advantageous responsible offeror, considering technical capability, price, and past performance.
75N95025Q00005-RFQ Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
12/20/24, 8:04 AM Assay Kits for Lumipulse instrument
The National Institute on Aging (NIA) seeks to acquire state-of-the-art assay kits for quantification of serum/plasma of abeta42, abeta40, and pTau 217 using Lumipulse assays on the Lumipulse G1200 instrument. The purpose is to leverage existing data on neuroimaging, cognitive, and clinical factors to understand cognitive and brain changes in healthy individuals and those with comorbidities. Vendors must provide documentation of their ability to meet the project requirements, including details on personnel qualifications, relevant contracts, and company information. Responses must be submitted electronically by October 28, 2024. This is a sources sought notice issued to determine the availability and capability of qualified sources, not a solicitation for proposals or quotes.
There is no set-aside designation for this opportunity. The government has not indicated any potential incumbents or current contractors. The notice does not provide any information on award values or budget ranges, nor does it specify the quantity of goods or timeline for services. The government reserves the right to use any non-proprietary technical information in any resultant solicitation.
75N95024Q00005-SS Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
10/17/24, 8:32 AM